Salmeterol + Fluticasone propionate (Saltrol) inhaler is for inhalation only.
Patients should be made aware that Salmeterol + Fluticasone propionate (Saltrol) must be used regularly for optimum benefit, even when asymptomatic.
Patients should be regularly re-assessed by a doctor, so that the strength of Salmeterol + Fluticasone propionate (Saltrol) they are receiving remains optimal and is only changed on medical advice.
Asthma (Reversible Obstructive Airways Disease): The dose should be titrated to the lowest dose at which effective control of symptoms is maintained. Where the control of symptoms is maintained with twice daily Salmeterol + Fluticasone propionate (Saltrol), titration to the lowest effective dose could include Salmeterol + Fluticasone propionate (Saltrol) given once daily.
Patients should be given the strength of Salmeterol + Fluticasone propionate (Saltrol) containing the appropriate Fluticasone propionate dosage for the severity of their disease.
If a patient is inadequately controlled on inhaled corticosteroid therapy alone, substitution with Salmeterol + Fluticasone propionate (Saltrol) at a therapeutically equivalent corticosteroid dose may result in an improvement in asthma control. For patients whose asthma control is acceptable on inhaled corticosteroid therapy alone, substitution with Salmeterol + Fluticasone propionate (Saltrol) may permit a reduction in corticosteroid dose while maintaining asthma control.
Adults and adolescents 12 years and older: Two inhalations of 25mcg salmeterol and 125mcg Fluticasone propionate twice daily. or Two inhalations of 25mcg salmeterol and 250mcg Fluticasone propionate twice daily.
Chronic Obstructive Pulmonary Disease (COPD): For adult patients the recommended dose is two inhalation 25mcg / 125mcg to 25mcg / 250mcg Salmeterol + Fluticasone propionate (Saltrol) twice daily.
Special population: There is no need to adjust the dose in elderly patients or in those with renal or hepatic impairment.
Other Services
Country
Account